WASHINGTON, April 30, 2019 /PRNewswire/ -- Dr. Scott Gottlieb, who left his position as commissioner of the Food and Drug Administration April 5, will speak at a National Press Club Headliners Luncheon on Friday, May 10 on his tenure at the agency. He will focus on how he moved his agenda thorough the agency and where he believes FDA should turn its attention in the future.
Lunch will be served in the club's Holeman Lounge at 12:30 p.m., with remarks beginning at 1 p.m., followed by a question-and-answer session ending at 2 p.m. Tickets cost $25 for National Press Club members (members may purchase two tickets at this rate) and $39 for all other non-member tickets. Please click here to purchase tickets.
Dr. Gottlieb was sworn in as the 23rd FDA commissioner on May 11, 2017. During his tenure, his agenda included increasing efficiency and consistency in the review process, lowering drug prices, developing tobacco and e-cigarette regulation, increasing the number of generic drugs approved by the FDA, addressing the opioid crisis, growing competition as a mechanism to make pharmaceuticals more accessible, and addressing the chronic staff shortage.
For all ticketing-related questions, please email [email protected]. Tickets must be paid for at the time of purchase. To submit a question for the speaker in advance, put FDA in the subject line and email to [email protected]. The deadline for submitting questions in advance is 10 a.m. on the day of the luncheon.
NPC Members who have a paid reservation to the Luncheon and wish to attend the pre-luncheon reception must send their RSVP via email to [email protected] at least 48 hours before the date of the Luncheon. Space may be limited.
The National Press Club is located on the 13th Floor of the National Press Building at 529 14th St., NW, Washington, D.C.
PRESS CONTACT: Lindsay Underwood, [email protected], (202) 662-7561
SOURCE National Press Club
Related Links
WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?
Newsrooms &
Influencers
Digital Media
Outlets
Journalists
Opted In
Share this article